Publications by authors named "A Lopez-Granados"
Introduction And Objectives: Our aim was to describe the characteristics and outcomes of heart transplants in Spain.
Methods: We analyzed trends in recipient and donor characteristics, recipient-donor interaction, surgical procedures, immunosuppression, and outcomes of patients included in the Spanish heart transplant registry from 2014 to 2023. Changes in survival were analyzed using the Kaplan-Meier method.
Background: The current incidence and outcomes of structural transcatheter procedures in heart transplant (HTx) recipients and left-ventricular assist devices (LVAD) carriers is unknown.
Aims: To provide insights on structural transcatheter procedures performed across HTx and LVAD patients in Spain.
Methods: Multicenter, ambispective, observational nationwide registry.
Introduction And Objectives: Posttransplant outcomes among recipients with a diagnosis of hypertrophic cardiomyopathy (HCM) or restrictive cardiomyopathy (RCM) remain controversial.
Methods: Retrospective analysis of a nationwide registry of first-time recipients undergoing isolated heart transplant between 1984 and 2021. One-year and 5-year mortality in recipients with HCM and RCM were compared with those with dilated cardiomyopathy (DCM).
Heart transplant (HT) remains the best therapeutic option for patients with advanced heart failure (HF). The allocation criteria aim to guarantee equitable access to HT and prioritize patients with a worse clinical status. To review the HT allocation criteria, the Heart Failure Association of the Spanish Society of Cardiology (HFA-SEC), the Spanish Society of Cardiovascular and Endovascular Surgery (SECCE) and the National Transplant Organization (ONT), organized a consensus conference involving adult and pediatric cardiologists, adult and pediatric cardiac surgeons, transplant coordinators from all over Spain, and physicians and nurses from the ONT.
View Article and Find Full Text PDFArticle Synopsis
- The Spanish heart transplant registry provides annual updates, with the latest focusing on data from 2022 regarding clinical characteristics and survival outcomes of heart transplants.
- In 2022, there were 311 heart transplants, marking a 3.0% increase from 2021, while demographic and clinical characteristics remained consistent with previous years.
- Over the past decade, survival rates have stabilized at 1 year (81.4%) and 3 years (73.4%), with a noted decrease in urgent transplants and the use of circulatory support devices.